KODIAK SCIENCES INC. Payments to Acquire Debt Securities, Available-for-sale
KODIAK SCIENCES INC. (KOD) reported Payments to Acquire Debt Securities, Available-for-sale of $40.23 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2019-11-12
- KODIAK SCIENCES INC. payments to acquire debt securities, available-for-sale for the quarter ending 2019-09-30 was $5.17M.
- KODIAK SCIENCES INC. payments to acquire debt securities, available-for-sale for the quarter ending 2019-06-30 was $11.20M.
- KODIAK SCIENCES INC. payments to acquire debt securities, available-for-sale for the quarter ending 2019-03-31 was $23.86M.
- KODIAK SCIENCES INC. payments to acquire debt securities, available-for-sale for the quarter ending 2018-09-30 was $0.00.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month |
|---|---|---|---|
| 2019-09-30 | $5.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $16.37M derived: sum of 2 quarters · filed 2019-11-12 | $40.23M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $11.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $35.07M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $23.86M 10-Q · filed 2019-05-15 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |